🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments

RecruitingNAAges 18 Years - anyAllOttawa Heart Institute Research Corporation
NCT04163081 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The INITIATE Study is a randomized controlled trial that is testing an intervention designed to increase long-term abstinence among tobacco smokers seen in emergency departments (ED) and other high-volume hospital and community ambulatory care settings. The intervention includes a behavioural incentive and tailored follow-up support on long-term smoking abstinence, health, healthcare utilization, and cost. Tobacco-related illnesses cost the healthcare system millions each year. Quitting smoking improves smoking-related outcomes, like the onset or management of heart disease, stroke, lung diseases, and several cancers. There are approximately 16 million visits to Canadian EDs each year; an estimated 3-4 million of these involve smokers. Effective quit smoking interventions exist, but are underutilized. Few hospital EDs, community healthcare centers, and other inpatient and outpatient clin

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Current daily smoker (smokes ≥ 5 cigarettes per day); * ≥ 18 years of age (the age of majority in Ontario); * For ED sites only, assigned a CTAS level of 2-5 (emergent to non-urgent); * Able to read and understand English or French; * Resides in Ontario and eligible for Ontario Health Insurance Plan (to permit linkage with administrative data housed at the Institute for Clinical Evaluative Sciences \[ICES\]); * Available and willing to participate in follow-up assessments over the next 12 months; * Has access to a telephone or computer; * Able to provide informed consent Exclusion Criteria: * Currently participating in this or another smoking cessation study; * For ED sites only, assigned a CTAS level of 1 (resuscitation - the most seriously ill patients with highest likelihood of hospital admission) or in psychiatric emergency unit; * Pregnant, planning to become pregnant over the next year, or breastfeeding; * Has morbid illness which will prevent completion of 26-week follow-up (e.g., receiving palliative care); * In the opinion of the attending physician, manifests acute physical and/or psychiatric illness or has cognitive impairment that would preclude participation in/benefit from the intervention. * Scheduled for a known elected surgery, procedure, or future hospitalization during the study period.
💊

What it tests

  • Quit Card Intervention (QCI)
📍

Where

4 sites
Civic Hospital
Ottawa, Canada
General Hospital
Ottawa, Canada
Riverside Hospital
Ottawa, Canada
University of Ottawa Heart Institute
Ottawa, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy